Elevated levels and activity of CSNK1D has been reported in AD post-mortem brain tissue and ALS (Ghoshal et al., 1999; Yasojima et al., 2000; Thal et al., 2011; Salado et al., 2014). Here, CSNK1D is linked to Alzheimer disease.